Legend Biotech to Participate in the 41st Annual JP Morgan Healthcare Conference

Author's Avatar
Jan 03, 2023

Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global biotechnology company developing, manufacturing and commercializing novel therapies to treat life-threatening diseases today announced its participation in the 41st annual JP Morgan Healthcare Conference in San Francisco, CA.